Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 12;15(1):12622.
doi: 10.1038/s41598-025-96821-x.

Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma

Affiliations

Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma

Anna Corti et al. Sci Rep. .

Abstract

With the advances in immunotherapy and the challenge of poor responsiveness in oral squamous cell carcinoma (OSCC) patients, understanding the tumor microenvironment is crucial. Radiogenomics offers the potential to provide pre-operative, non-invasive image-derived immune biomarkers. To this aim, the present study explores the capability of MRI-based radiomics to describe patients' immune state in OSCC. Seven MRI-based radiomic, 29 immune-related gene expression signatures were computed and deconvolution analysis was performed for a subset of OSCC from the BD2Decide database. A correlation-driven analysis identified key associations between radiomic and immune-related signatures and cell populations. Radiomic classifiers of the gene expression signatures were then developed to evaluate their capability to stratify patients based on immune status. MRI-based radiomic models showed promising results in predicting a gene expression signature associated with significant prognostic value for HNSCC patients who underwent radiotherapy (AUC = 0.92), suggesting these models' potential in distinguishing radioresistant from radiosensitive patients, aiding treatment decisions. Additionally, radiomic signatures reflected immune infiltrating cells in our cohort (M1, CD8 + T, B cells). MRI-radiomic signatures and associated models could become non-invasive methods to evaluate the prognosis and treatment choice in OSCC patients. Based on our promising results, and upon external validation, MRI-radiomics could enhance personalized medicine approaches.

Keywords: Cluster analysis; Head and neck cancer; Magnetic resonance imaging; Radiogenomic; Radiomic features; Transcriptomic signatures; Tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: The protocols were approved by the Ethical Committees of the participating centers, and data acquisition followed the General Data Protection Regulation of the EU. All patients signed the informed consent. Consent for publication: All authors have read and approved the manuscript and agree with submission.

Figures

Fig. 1
Fig. 1
Consort.
Fig. 2
Fig. 2
Correlation-driven clustering and dendrogram between the 7 radiomic (R) signatures and the selected 15 gene expression (G) signatures. Only stable clusters were depicted. Spearman’s correlation coefficient (ρ) was computed between each R and G signature. The main characteristics of R and G signatures are respectively reported in Tables 2 and 3.
Fig. 3
Fig. 3
Paired scatter plots between the 7 radiomic signatures (R1-R7) and correlation matrix heatmap of Spearman’s correlation coefficient (ρ).
Fig. 4
Fig. 4
Paired scatter plots between the 15 gene expression (G) signatures and correlation matrix heatmap of Spearman’s correlation coefficient (ρ).
Fig. 5
Fig. 5
Median balanced accuracy and area under the receiver operating characteristic curve (AUC) over 100 repetitions of the single radiomic models (top) and combined radiomic model (bottom) of each gene expression signature included in the study.
Fig. 6
Fig. 6
Correlation between radiomic signatures (R1-R7) and immune populations identified by Cibersort in the 82 OSCC patients. Spearman’s correlation coefficient (ρ) was computed.

References

    1. Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.74, 229–263 (2024). - PubMed
    1. Bao, J., Betzler, A. C., Hess, J. & Brunner, C. Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma. Front. Immunol.14, 1233085 (2023). - PMC - PubMed
    1. Damasio, M. et al. The role of T-cells in head and neck squamous cell carcinoma: from immunity to immunotherapy. Front. Oncol.12, 1021609 (2022). - PMC - PubMed
    1. Ruffin, A. T. et al. Improving head and neck cancer therapies by Immunomodulation of the tumour microenvironment. Nat. Rev. Cancer. 23, 173–188 (2023). - PMC - PubMed
    1. Moskovitz, J., Moy, J. & Ferris, R. L. Immunotherapy for head and neck squamous cell carcinoma. Curr. Oncol. Rep.20, 22 (2018). - PMC - PubMed

MeSH terms

Substances